Maravai LifeSciences Inc... (MRVI)
NASDAQ: MRVI
· Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.62
0.19%
After-hours: Aug 15, 2025, 06:49 PM EDT
Maravai LifeSciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -224.97M | -162.71M | -144.85M | -224.66M | -132.08M | -136.44M | -125.71M | 67.68M | 173.79M | 342.45M | 490.66M | 529.48M | 562.63M | 540.26M | 469.25M | 357.48M | 263.69M | 130.79M |
Depreciation & Amortization | 57.39M | 58.78M | 57.62M | 56.07M | 54.38M | 51.63M | 48.78M | 45.83M | 42.64M | 41.63M | 38.1M | 31.52M | 28.68M | 25.24M | 24.75M | 27.23M | 26.83M | 25.96M |
Stock-Based Compensation | 40.79M | 47.76M | 49.41M | 48.21M | 45.15M | 40.66M | 34.59M | 31.24M | 25.99M | 21.03M | 18.67M | 14.9M | 13.73M | 11.81M | 10.46M | 29.92M | 28.21M | 26.4M |
Other Working Capital | -5.52M | -6.58M | -27.83M | -14.89M | -10.16M | -7.7M | 7.52M | -9.96M | -23.89M | -31.97M | -30.69M | -81.5M | -113.68M | -124.4M | -85.34M | -9.79M | 88.03M | 109.53M |
Other Non-Cash Items | 101.69M | 56.53M | 55.22M | -617.24M | -698.29M | -698.48M | -684.22M | -3.88M | -1.91M | -5.44M | -8.7M | -229K | -11.17M | -1.49M | -6.16M | -13.3M | 1.91M | 2.7M |
Deferred Income Tax | 11K | 11K | 11K | 765.06M | 759.22M | 756.46M | 754.94M | -2.8M | 11.97M | 27.58M | 42.32M | 52.77M | 54.77M | 48.36M | 46.9M | 25.25M | 14.02M | 7.57M |
Change in Working Capital | 3.94M | 6.18M | -9.95M | 2.44M | 2.55M | 18.86M | 97.84M | 79.7M | 61.18M | 31.5M | -45.08M | -133.64M | -158.04M | -132.01M | -176.63M | -36.75M | 748K | -12.23M |
Operating Cash Flow | -21.16M | 6.54M | 7.46M | 29.89M | 30.92M | 32.68M | 126.22M | 217.77M | 313.66M | 458.75M | 535.98M | 494.81M | 490.61M | 492.16M | 368.57M | 389.83M | 335.41M | 181.19M |
Capital Expenditures | -23.05M | -29.73M | -30.16M | -40.61M | -47.84M | -63.35M | -65.55M | -54.97M | -45.61M | -22.21M | -17.09M | -16.54M | -11.48M | -14.02M | -14.85M | -18.04M | -26.72M | -25.58M |
Cash Acquisitions | -18.99M | -18.63M | n/a | 74.91M | 74.91M | 75.02M | 5.29M | -69.75M | -69.14M | -69.24M | -238.35M | -238.22M | -118.88M | -118.88M | 120.5M | 117.48M | -2.48M | -2.48M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.28M | 4.66M | 5.34M | -66.59M | -65.92M | -68.49M | -62.05M | -3.2M | -2.89M | -3.68M | -11.55M | 620K | 119.96M | 119.96M | 120.5M | 123.53M | 3.57M | 3.57M |
Investing Cash Flow | -40.26M | -43.2M | -24.32M | -32.29M | -38.85M | -56.82M | -122.31M | -127.93M | -118.25M | -95.76M | -267.61M | -254.75M | -130.36M | -132.9M | 105.66M | 102.47M | -26.17M | -25.03M |
Debt Repayment | -232.6M | -234.11M | -234.07M | -6.04M | -6M | -5.92M | -5.77M | -5.63M | -5.51M | -5.44M | -5.44M | -5M | -5.36M | -5.72M | -6M | 178.74M | 179.89M | 180.94M |
Common Stock Repurchased | -621K | -649K | -2.08M | -1.48M | -1.46M | -1.43M | -333K | -333K | -333K | -333K | n/a | n/a | n/a | n/a | n/a | -42.8M | -42.8M | -42.8M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.62M | 681K | 1.68M | 8.81M | 8.73M | -34.74M | -54.63M | -121.72M | -160.07M | -160.41M | -182.06M | -165.76M | -179.24M | -169.59M | -152.99M | -247.68M | -198.48M | -166.27M |
Financial Cash Flow | -240.57M | -238.81M | -234.47M | 947K | 921K | -42.44M | -61.09M | -127.68M | -165.91M | -166.19M | -187.5M | -170.37M | -184.43M | -175.37M | -159.05M | -69.38M | -18.82M | 14.67M |
Net Cash Flow | -303.26M | -276.64M | -252.56M | -1.45M | -7M | -66.58M | -57.18M | -37.84M | 29.5M | 196.8M | 80.87M | 69.55M | 175.97M | 183.79M | 315.09M | 423.02M | 290.25M | 170.93M |
Free Cash Flow | -44.21M | -23.19M | -22.69M | -10.71M | -16.92M | -30.67M | 60.67M | 162.8M | 268.05M | 436.54M | 518.89M | 478.27M | 479.13M | 478.14M | 353.72M | 371.8M | 308.68M | 155.61M |